Skip to main content
JMIR Public Health and Surveillance logoLink to JMIR Public Health and Surveillance
. 2025 Sep 17;11:e71677. doi: 10.2196/71677

Identifying Predictors of Cervical Cancer Screening Uptake in Sub-Saharan Africa Using Machine Learning: Cross-Sectional Study

Nebebe Demis Baykemagn 1,, Mekuriaw Nibret Aweke 2, Amare Mesfin 2, Lemlem Daniel Baffa 2, Muluken Chanie Agimas 3, Habtamu Wagnew Abuhay 3, Dagnew Getnet Adugna 4, Tewodros Getaneh Alemu 5, Alemu Teshale Bicha 6, Gebrie Getu Alemu 3
Editor: John Tayu Lee
PMCID: PMC12443358  PMID: 40961361

Abstract

Background

Cervical cancer has been ranked as the fourth most common cancer affecting women, contributing to approximately 660,000 new diagnoses and 350,000 fatalities worldwide. Effective early screening has been shown to reduce cervical cancer incidence by up to 80% and prevent more than 40% of new cases.

Objective

This study aims to assess a machine learning–based prediction model and identify the key predictors influencing cervical cancer screening uptake among women aged 30‐49 years in sub-Saharan Africa.

Methods

For this study, a weighted dataset of 33,952 individuals from the 2022 Demographic and Health Survey in Ghana, Kenya, Mozambique, and Tanzania was used. STATA version 17 (StataCorp) and Python 3.10 (Python Software Foundation) were used for data preprocessing and analysis. MinMax and standard scaler were applied for feature scaling, and recursive feature elimination was used for feature selection. An 80:20 ratio was applied for data splitting. Tomek links with random oversampling were used for handling class imbalance. A total of 7 models were selected and trained using both balanced and unbalanced datasets. Model evaluation was performed using area under the receiver operating characteristic curve, accuracy, and a confusion matrix.

Results

The proportion of cervical cancer screening in sub-Saharan Africa was 13%, which is lower than reported in previous studies. Random forest was the best-performing model, achieving an accuracy of 78%, an area under the curve of 86%, an F1-score of 79%, a recall of 81%, and a precision of 77%. The waterfall plot’s Shapley Additive Explanations analysis showed that wealth status, awareness of sexually transmitted infections, HIV testing exposure, age at first sexual intercourse, educational level, residency, smartphone ownership, having a single sexual partner, and previous health status were predictors of cervical cancer screening.

Conclusions

Improving education and awareness, expanding access to screening (especially in rural areas), leveraging both digital health and community-based outreach, integrating screening with other health services, and addressing socioeconomic barriers are recommended strategies to increase cervical cancer screening rates in sub-Saharan Africa.

Introduction

Cervical cancer has been ranked as the fourth most common cancer affecting women, contributing to approximately 660,000 new diagnoses and 350,000 fatalities globally [1]. About 75%‐85% of these cases occur in low-income countries, with 23% specifically in Africa (as reported by the World Health Organization [WHO]). The incidence and mortality rates of cervical cancer are 2-3 times higher in low-income countries compared to high-income countries [2].

Cervical cancer ranks as the second leading cause of cancer-related death globally [3]. In 2025, studies from Africa showed that cervical cancer screening prevalence differs significantly between high-income countries (84%) and low- and middle-income countries (15%) [4]. Also, in Africa, more than 53% of cervical cancer cases are identified at an advanced stage (stage III-IV) [5].

Cervical cancer is “a malignant tumor that forms when the cells in the tissue surrounding the cervix grow and multiply uncontrollably by passing the normal process of cell division” [6]. Effective early screening has been shown to reduce cervical cancer incidence by up to 80% and prevent more than 40% of new cases [2,7].

With an average cure rate of 80%, radiation therapy effectively treats cervical cancer in its early stages [8]. However, the practice of early screening, before the disease reaches an advanced stage, continues to be a major problem in many parts of Africa [5].

Despite the implementation of screening initiatives and the introduction of the human papillomavirus (HPV) vaccine, cervical cancer remains a significant public health concern in Africa [9].

Early detection and timely treatment of cervical cancer are crucial [10]. The HPV has more than 100 serotypes, but the HPV vaccine targets only 9 of them [11]. Also, early screening is a key approach to achieving 1 of the 3 WHO 90-70-90 pillars: “90% of girls fully vaccinated against HPV, 70% of women screened by age 35 and 45 with a high-performance test, and 90% of women with precancerous lesions receiving treatment” [12,12].

Therefore, early screening is essential to enhance the probability of early diagnosis and treatment. Early screening is guaranteed to identify precancerous lesions and cancer before symptoms appear, which is the goal of screening, and enhances the chances of successful treatment and reduces maternal mortality [12-14].

However, studies show that screening in Africa is conducted at less than 70% of the WHO target [15]. This is due to a perceived lack of expertise, limited knowledge about cervical cancer, inadequate screening tools and supplies, and insufficient funding [5,16,17]. In the recent study, the prevalence of precancerous cervical lesions and cancer is relatively high, at 18% and 14%, respectively [18].

According to previous studies conducted in Africa, age, education level, employment status, wealth index, place of residence, and access to health care facilities were common predictors of cervical cancer screening among women of reproductive age [19-22].

Although studies have been conducted in African countries, they were limited to small sample sizes and single countries, lacking representativeness. This study, however, is representative, with a large dataset covering multiple countries, providing reliable evidence for policymakers and researchers to inform interventions.

The health care system produces vast amounts of data that must be analyzed to support effective decision-making. As the volume and complexity of this data grow, relying on traditional analytical methods without the aid of machine learning is becoming increasingly impractical.

A key strength of machine learning is its ability to handle big datasets while delivering reliable performance metrics. Although this study focuses on sub-Saharan Africa, the application of machine learning in this context allows for the extraction of meaningful patterns from complex health data.

Methods

Data Processing and Management

After deciding on the title by considering the current public health issue, data were extracted from the individual record dataset. Then, the relationships between all variables and the outcome were reviewed based on previous study evidence and expert opinions. The similarity of the selected variables across 4 countries (Ghana, Kenya, Mozambique, and Tanzania) that had recent (2022‐2023) Demographic and Health Surveys (DHS) data available was checked. STATA version 17 (StataCorp) and Python 3.10 (Python Software Foundation) were used for data processing and management. To handle missing data, mode imputation and K-nearest neighbors imputation were used to maintain the data distribution, ensure statistical consistency, and preserve the integrity of the dataset (Figure 1).

Figure 1. Overview flowchart of data preparation and analysis plan applied. ANN: artificial neural network; DHS: Demographic and Health Surveys; DT: decision tree; GB: gradient boosting; KNN: K-nearest neighbors; LGMB: light gradient boosting machine; RF: random forest; XGB: extreme gradient boosting.

Figure 1.

Many machine learning algorithms are sensitive to the scale of features and need normalization before modeling [23]. MinMaxScaler and StandardScaler were applied to normalize or standardize our data, ensuring a consistent scale and improving the performance of modeling tasks. The goal is to minimize performance bias in models that are sensitive to feature scaling, as the absence of standardization can negatively impact model performance.

Feature Selection

Recent studies indicate that irrelevant variables weaken the model’s capacity for generalization, raise its overall complexity, and possibly lower a classifier’s overall accuracy in a machine learning study [24]. Recursive feature elimination was used to methodically remove irrelevant features, decreasing dimensionality while retaining the most important predictive variables, thereby enhancing the model’s efficiency and ability to generalize (Figure 2).

Figure 2. The top 10 features of cervical cancer screening. SHAP: Shapley Additive Explanations.

Figure 2.

Splitting the Data

Previous studies indicate that data splitting offers a trustworthy estimation of the model’s performance on unseen data and aids in the detection of overfitting [25]. For data splitting, an 80:20 ratio was used for training and testing, respectively, to assess the model’s performance and prevent overfitting in machine learning algorithms.

Handling Imbalanced Data

In machine learning, class imbalance is frequently encountered due to unbalanced data, and this can have a big influence on model accuracy [26].

To improve model generalization and minimize noise and class overlap, we applied the synthetic minority oversampling technique (SMOTE) in combination with Tomek links undersampling. This process resulted in a balanced and cleaner dataset, where the original distribution of 3878 “yes” cases and 30,074 “no” cases was adjusted to 30,074 instances in each class.

Model Selection

After a detailed review of machine learning studies conducted on reproductive health, 7 models were selected based on simplicity, accuracy, robustness, and computational efficiency, including decision tree, random forest (RF), K-nearest neighbors, extreme gradient boosting, light gradient boosting machine, adaptive boosting, and gradient boosting (GB).

Model Training

Both balanced and unbalanced datasets were used to train the selected classifiers after the model was selected. They used 10-fold cross-validation to assess their performance. In order to generate final predictions on test data that had not yet been observed, the best successful predictive model was selected after the comparison and trained using balanced training data.

Hyperparameter Tuning

A crucial step in maximizing the potential of machine learning models and ensuring their accuracy, efficiency, and robustness is hyperparameter tuning. Hyperparameter tuning by RF is listed in Table 1.

Table 1. Hyperparameters and values for all models.

Classifier Hyperparameter and value
DTa max_depth=10, criterion=gini, min_samples_split=10, min_sample_leaf=1,
RFb max_depth=20,min_samples_split=10, n_estimators=300
KNNc n_neighbors=5, weights='uniform’, metric='minkowski’
ANNd hidden_layer_sizes=(100,), activation='relu’, solver='adam’, learning_rate='adaptive’, max_iter=300
XGBe colsample_bytree=0.8, learning_rate=0.05, max_depth=3, n_estimators=100,
subsample=1.0
LGBMf learning_rate=0.1, n_estimators=20, num_leaves=31
ADAg n_estimators=300, learning_rate=1.0
GBh n_estimators=300, learning_rate=0.1, max_depth=3, min_samples_split=10
a

DT: decision tree.

b

RF: random forest.

c

KNN: K-nearest neighbors.

d

ANN: artificial neural network.

e

XGB: extreme gradient boosting.

f

LGBM: light gradient boosting machine.

g

ADA: adaptive boosting.

h

GB: gradient boosting.

Model Evaluation

Model evaluation was performed using confusion matrix, F1-score, area under the receiver operating characteristic curve, accuracy, precision, and recall in this study. Ultimately, the RF model outperformed others due to its effectiveness in handling nonlinear relationships, evaluating feature importance, and minimizing overfitting through the ensemble of multiple decision trees. For results, see Figure 3 and Tables2 3.

Figure 3. ROC curve for model comparison to predict cervical cancer screening. ADA: adaptive boosting; AUC: area under the curve; DT: decision tree; GB: gradient boosting; KNN: K-nearest neighbors; LGMB: light gradient boosting machine; RF: random forest; ROC: receiver operating characteristic; XGB: extreme gradient boosting.

Figure 3.

Table 2. Model evaluation after synthetic minority oversampling technique.

Model Accuracy (%) AUCa (%) F1-score (%) Recall (%) Precision (%)
DTb 78 85 78 80 76
RFc 78 86 79 81 77
KNNd 72 80 74 75 73
XGBooste 76 83 76 78 75
LGBMf 74 81 75 76 74
ADAg 72 77 71 73 69
GBh 72 79 72 74 70
a

AUC: area under the curve.

b

DT: decision tree.

c

RF: random forest.

d

KNN: K-nearest neighbors.

e

XGBoost: extreme gradient boosting.

f

LGBM: light gradient boosting machine.

g

ADA: adaptive boosting.

h

GB: gradient boosting.

Table 3. Confusion matrix for cervical cancer prediction by random forest accuracy (2802+2494+837+658=6791=78%).

Predicted positive Predicted negative
Actual positive 2802 (true positive) 658 (false negative)
Actual negative 837 (false positive) 2494 (true negative)

Ethical Considerations

This study did not require institutional review board approval because it involved secondary analysis of publicly available and deidentified data from the DHS Program. As a result, a consent letter for data access was obtained from a major health and demographic survey program via a web-based request submitted at the DHS Program website [27]. All data used in this study consisted of nonidentifiable information.

Results

Cervical Cancer Screening Distribution by Country

The proportion of women screening rates in Kenya (14%), Mozambique (13%), Tanzania (12%), and Ghana (7%) remains low (Table 4).

Table 4. Cervical cancer screening distribution by country.

Country Categories
Yes, n (%) No, n (%)
Ghana 530.8 (7) 6767.2 (92)
Kenya 2053 (14) 12,389 (85)
Mozambique 669 (13) 4575.8 (88)
Tanzania 842.6 (12) 6068.1 (88)

Individual Characteristics of Cervical Cancer Screening

The majority of women living in rural (17,987.6/19,690.1, 91%) and urban areas (11,812.7/14,205.8, 83%) have not undergone cervical cancer screening. Among women who own a smartphone, 2170.8 of 11,628.9 (19%) have been screened for cervical cancer, while only 1924.8 of 22,267.0 (9%) of those without a smartphone have been screened.

Women who self-report good health status have a cervical cancer screening rate of 15% (156.9/1,056.6) compared to 11% (2762.9/24,302.6) among those who report poor health status. Women with high wealth status have a cervical cancer screening rate of 18% (2884.8/15,923.9), compared to 5% (604.5/11,398.8) among those in the poorest wealth category.

Only 286.1 of 1875.2 (15%) women who use family planning methods have been screened for cervical cancer. Those who do not consider distance a big problem had a slightly higher screening rate (3226.1/26,048.9, 12%). Women who initiated sexual activity after the age of 30 years had a screening rate of 14% (1932.9/13,527.5), higher than the 11% (2162.7/20,368.2) among those who began before the age of 30 years.

Women reporting multiple sexual partners had a significantly higher screening rate (793.2/4218, 19%) than those who did not (3302.5/29,677.9, 11%). Women who have been tested for HIV have a cervical cancer screening rate of 13% (3958.3/29,777), compared to only 3% (137.3/4118.9) among those who have not been tested. Divorced and widowed women show slightly higher screening rates at 15% (676.3/4638.9) and 14% (258.5/1879.7), respectively.

Women with tertiary education have a screening rate of 22% (838.7/3738.8), compared to only 4% (238.6/6572.2) among those with no education. Women who have heard about sexually transmitted infections (STIs) have a screening rate of 17% (3900.8/23,313.8), compared to only 1.9% (194.8/10,582.1) among those who have not (Table 5).

Table 5. Individual characteristics of cervical cancer screening.

Variables and categories Yes, n (%) No, n (%)
Residence
 Urban 2393.1 (17) 11,812.7 (83)
 Rural 1702.5 (9) 17,987.6 (91)
Frequently social media usage

 No
2873.5 (12) 20,629.5 (88)
 Yes 1222.2 (12) 9170.8 (88)
Availability of smartphone

 No
1924.8 (9) 20,342.2 (91)
 Yes 2170.8 (19) 9458.1 (81)
Self-report of health status

 Good
156.9 (15) 899.7 (85)
 Moderate 1175.9 (14) 7360.8 (86)
 Poor 2762.9 (11) 21,539.7 (88)
Wealth

 Lowest
604.5 (5) 10,794.3 (94)
 Middle 606.3 (9) 5966.9 (91)
 Highest 2884.8 (18) 13,039.1 (82)
Family planning method use

 No
3809.5 (12) 28,211.2 (88)
 Yes 286.1 (15) 1589.1 (84)
Distance to health facility

 Big problem
869.6 (11) 6977.4 (88)
 Not a big problem 3226.1 (12) 22,822.8 (87)
Age at first sexual intercourse (years)

 >30
1932.9 (14) 11,594.6 (85)
 <30 2162.7 (11) 18,205.5 (89)
Have multiple sexual partners

 No
3302.5 (11) 26,375.4 (89)
 Yes 793.2 (19) 3424.8 (81)
Tested for HIV/AIDS

 No
137.3 (3) 3981.6 (96)
 Yes 3958.3 (13) 25,818.7 (86)
Marital status

 Single
254 (13) 1751.7 (87)
 Married 2906.7 (12) 22,464.6 (89)
 Widowed 258.5 (14) 1621.2 (86)
 Divorced 676.3 (15) 3962.6 (85)
Educational status

 No education
238.6 (4) 6333.6 (96)
 Primary 1668.7 (12) 12,746.3 (88)
 Secondary 1349.6 (15) 7820.2 (85)
 Tertiary 838.7 (22) 2900.1 (78)
Heard about STIa

 No
194.8 (1.9) 10,387.3 (98)
 Yes 3900.8 (17) 19,413 (83)
a

STI: sexually transmitted infection.

Determinants of Cervical Cancer Screening

In machine learning, Shapley Additive Explanations (SHAP) values indicate how each feature impacts the output variable. This study examines the impact of the top 10 features on women’s cervical cancer screening status. These insights are crucial for specific interventions and policy formulation aimed at enhancing cervical cancer screening practices, as well as reducing morbidity and mortality among women.

In Figure 4, a feature contributing positively to the predicted screening practice is represented by a positive SHAP value (red), while a feature contributing negatively to the predicted screening outcome is represented by a negative SHAP value (blue).

Figure 4. Determinants of cervical cancer screening visualized by a waterfall plot.

Figure 4.

The best predictive model (RF) showed that wealth status, awareness of STIs, HIV testing, age at first sex, primary education and above, and living in urban areas are significant factors associated with increased cervical cancer screening. However, factors such as not owning a smartphone, having a single sexual partner, and unknown health status are associated with a decrease in cervical cancer screening (Figure 4).

Discussion

Principal Findings

In sub-Saharan Africa, cervical cancer is the second most common cause of cancer-related death on the continent and the fourth leading cause of cancer-related death globally [28,29]. Low- and middle-income countries account for nearly 85% of cervical cancer cases and related deaths [28]. However, according to this study, a small percentage of women were screened for cervical cancer in Kenya (14.22%), Mozambique (12.76%), Tanzania (12.20%), and Ghana (7.27%). This low screening rate contributes to delays in early cancer management and highlights the urgent need for targeted interventions to improve screening behaviors among women.

The predictive evidence from this machine is used to support the realization of the 2030 plan [30]: 90% of cervical diseases identified, 90% of precancerous cases treated, and 90% of women with invasive cancer managed.

The RF is the best-performing model, achieving an accuracy of 78%, an area under the curve of 86%, an F1-score of 79%, a recall of 81%, and a precision of 77%. The waterfall plot’s SHAP analysis indicates that variables, such as middle and higher wealth status, awareness of STIs, HIV testing, age at first sex, primary education and above, and living in urban areas are significant factors associated with increased cervical cancer screening.

However, not having a smartphone, having a single sexual partner, and being unaware of health status are associated with a decrease in cervical cancer screening.

In this study, the proportion of cervical cancer screening is 13%, which is higher than findings from studies conducted in Cameroon (4%) [2], South India (7.1%) [31], and lower than those reported in Ethiopia (14.79%) [32], and sub-Saharan Africa (19%) [33]. Possible justifications for this difference may include public awareness levels, accessibility of screening services, outreach programs, community health education, socioeconomic status, and geographic barriers. Differences in study populations, sampling methods, and time frames may also contribute to these variations [34].

According to this finding, women with middle and higher wealth status have increased cervical cancer screening rates, which is supported by previous research conducted in the United States, Ethiopia, Uganda, and Cameroon [2,35-37,undefined,undefined]. One explanation could be that women with middle-class and upper-class incomes have easier access to health care because they can afford the direct and indirect costs of medical care, including transportation and other costs.

This finding shows that women who have information about STIs are more likely to undergo cervical cancer screening. This is supported by previous studies conducted in Southern Ethiopia, Eastern and Southern Africa, Haiti, and Morocco [38-41]. This is because women who have information about STIs are also exposed to information about cervical cancer, including the benefits of early screening, and they tend to have better health-seeking behavior.

According to this SHAP finding, women who do not have smartphones show decreased cervical cancer screening rates. This is supported by previous studies conducted in Japan and England [42,43]. Those who have smartphones can easily access health information, including preventive health care such as screenings, through websites, mobile apps, and social media. Those who do not have smartphones may miss this information and, as a result, may not pay attention to screening [44].

The SHAP finding showed that women who have previously been tested for HIV are more likely to undergo cervical cancer screening. This is consistent with previous studies conducted in Uganda, China, Kenya, and Ethiopia [45-48].

Also, this study indicated that women who did not have information about their health status had decreased cervical cancer screening practices. This is supported by previous studies conducted in Nigeria, Ghana, Australia, India, and Kenya [49-53]. Women who do not have information about their health status are less likely to undergo cervical cancer screening because a lack of awareness reduces their understanding of risk, engagement with health care, and motivation to seek preventive services.

This study showed that women who had their first sexual intercourse before the age of 30 years had an increased cervical screening status. This is in line with studies conducted in East Gojjam Zone, Ethiopia, Africa, and Nigeria [54-56]. A possible explanation for this is that early sexual activity is associated with a higher likelihood of STIs, which in turn leads to more frequent visits to health facilities due to increased awareness of cervical cancer risk.

In addition, women in this age group are more educated and more likely to understand messages from social media and health professionals, including information about cervical cancer risk and the benefits of early screening and treatment [56].

SHAP findings showed that women who have a single sexual partner have decreased cervical cancer screening rates. This finding was supported by studies conducted in Korea, Jordan, Ethiopia, and Uganda [57-60].

Women with a single partner have high confidence that they are free from cervical cancer risk factors because, during health facility visits and through social media information, they understand that women with single sexual partners are at a lower risk of contracting HPV and other STIs, which are the main causes of cervical cancer [61].

This finding also showed that women with primary and higher education levels have increased cervical cancer screening status, which is in line with previous studies conducted in Romania, the Southwest United States, Mayuge, Ghana, and Korea [62-66].

A possible explanation for this could be that educated women have greater health literacy, allowing them to easily understand basic health information and services, including information about cervical cancer. Educated women also tend to have better access to resources such as health care providers, smartphones, and official websites like those of the WHO.

In addition, they may be less influenced by cultural misconceptions or stigma surrounding cervical cancer screening [67].

SHAP findings also showed that women residing in urban areas had increased cervical cancer screening rates. This is in line with previous studies conducted in Nepal, Nigeria, China, and Ghana [55,68-70,undefined,undefined]. Women residing in urban areas have improved access to health information and services through social media, public health campaigns, and proximity to health care facilities and professionals. Consequently, they tend to have a better understanding of cervical cancer compared to their rural counterparts [71].

Strengths and Limitations

One of the study’s strengths is that it makes use of a large and varied dataset, which improves the findings’ applicability to a larger geographic area. Furthermore, complex patterns and relationships that traditional statistics can miss might be found through the use of machine learning models, and the limitations of this include issues that can impact prediction accuracy, such as self-reported information, recall bias, and missing data. Furthermore, it is challenging to determine causal links due to the cross-sectional nature of data, and the findings based on machine learning outputs should be interpreted as associations rather than causations.

Conclusions

Wealth status, awareness of STIs, HIV testing exposure, age at first sexual intercourse, educational level, residency, smartphone ownership, having a single sexual partner, and previous health status are predictors of cervical cancer screening.

Improving education and awareness, expanding access to screening, especially in rural areas, leveraging both digital health and community-based outreach, integrating screening with other health services, and addressing socioeconomic barriers are recommended strategies to increase cervical cancer screening rates in sub-Saharan Africa.

Acknowledgments

The authors would like to express their gratitude for the valuable time and expertise provided by everyone involved in this study. All authors declared that they had insufficient funding to support open access publication of this manuscript, including from affiliated organizations or institutions, funding agencies, or other organizations. JMIR Publications provided article processing fee (APF) support for the publication of this article.

Abbreviations

DHS

Demographic and Health Survey

LR

logistic regression

RF

random forest

SHAP

Shapley Additive Explanations

STI

sexually transmitted infection

WHO

World Health Organization

Footnotes

Authors’ Contributions: NDB, GGA, and MNA developed the concept for the study. AM, LDB, MCA, HWA, DGA, TGA, and ATB reviewed the literature. NDB, GGA, MNA, and HWA conducted the data analysis. NDB, GGA, MNA, HWA, and DGA discussed the findings.

Data Availability: The datasets analyzed in this study are available in the public domain through the Measure DHS website [72].

Conflicts of Interest: None declared.

References

  • 1.Cervical cancer. World Health Organization. [18-08-2025]. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer URL. Accessed.
  • 2.Okyere J, Duodu PA, Aduse-Poku L, Agbadi P, Nutor JJ. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys. BMC Public Health. 2021 Jun 5;21(1):1071. doi: 10.1186/s12889-021-11024-z. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Amorha KC, Ozota GO, Ndunwere MGO, Anyaji UL, Egbo OF, Ogugofor OA. Knowledge, attitudes, and practices of adolescent girls regarding cervical cancer: a cross-sectional study in Enugu State, Nigeria. Pan Afr Med J. 2024;47:17. doi: 10.11604/pamj.2024.47.17.41087. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Olivieri DJ, Eastment MC, Mugisha N, Menon MP. Correlates of cervical cancer awareness among women aged 30-49 in five sub-Saharan African nations: evidence from the Demographic and Health Survey (DHS)-2017-2023. PLOS Glob Public Health. 2025;5(5):e0003344. doi: 10.1371/journal.pgph.0003344. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in Africa: a systematic review. BMC Public Health. 2024 Feb 20;24(1):525. doi: 10.1186/s12889-024-17842-1. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Uddin KMM, Al Mamun A, Chakrabarti A, Mostafiz R, Dey SK. An ensemble machine learning-based approach to predict cervical cancer using hybrid feature selection. Neuroscience Informatics. 2024 Sep;4(3):100169. doi: 10.1016/j.neuri.2024.100169. doi. [DOI] [Google Scholar]
  • 7.Saaka SA, Hambali MG. Factors associated with cervical cancer screening among women of reproductive age in Ghana. BMC Womens Health. 2024 Sep 18;24(1):519. doi: 10.1186/s12905-024-03367-7. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shakil R, Islam S, Akter B. A precise machine learning model: detecting cervical cancer using feature selection and explainable AI. J Pathol Inform. 2024 Dec;15:100398. doi: 10.1016/j.jpi.2024.100398. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ong SK, Abe SK, Thilagaratnam S, et al. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 2023 Oct;39:100860. doi: 10.1016/j.lanwpc.2023.100860. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.WHO Regional Office for Africa; Nov, 2024. [10-09-2025]. Advancing the cervical cancer elimination agenda in the African region.https://www.afro.who.int/media-centre/statements-commentaries/advancing-cervical-cancer-elimination-agenda-african-region URL. Accessed. [Google Scholar]
  • 11.Human Papillomavirus (HPV) Infection. International Agency for Research on Cancer; 2007. [10-09-2025]. https://www.ncbi.nlm.nih.gov/books/NBK321770/ URL. Accessed. [Google Scholar]
  • 12.Beyene T, Akibu M, Bekele H, Seyoum W. Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: unmatched case-control study. PLoS One. 2021;16(7):e0254663. doi: 10.1371/journal.pone.0254663. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Holcakova J, Bartosik M, Anton M, et al. New trends in the detection of gynecological precancerous lesions and early-stage cancers. Cancers (Basel) 2021 Dec 17;13(24):6339. doi: 10.3390/cancers13246339. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yan T, Wong PK, Qin YY. Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: a review. World J Gastroenterol. 2021 May 28;27(20):2531–2544. doi: 10.3748/wjg.v27.i20.2531. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yang L, Boily MC, Rönn MM, et al. Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: a systematic analysis of population-based surveys (2000-2020) PLoS Med. 2023 Jan;20(1):e1004143. doi: 10.1371/journal.pmed.1004143. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Adewumi K, Nishimura H, Oketch SY, Adsul P, Huchko M. Barriers and facilitators to cervical cancer screening in Western Kenya: a qualitative study. J Cancer Educ. 2022 Aug;37(4):1122–1128. doi: 10.1007/s13187-020-01928-6. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tshabalala G, Blanchard C, Mmoledi K, et al. A qualitative study to explore healthcare providers’ perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa. PLOS Glob Public Health. 2023;3(5):e0001826. doi: 10.1371/journal.pgph.0001826. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tenkir L, Mamuye A, Jemebere W, Yeheyis T. The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in Southern Ethiopia, 2021: a cross-sectional study. Front Glob Womens Health. 2023;4:1187916. doi: 10.3389/fgwh.2023.1187916. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ampofo AG, Boyes AW, Asibey SO, Oldmeadow C, Mackenzie LJ. Prevalence and correlates of modifiable risk factors for cervical cancer and HPV infection among senior high school students in Ghana: a latent class analysis. BMC Public Health. 2023 Feb 15;23(1):340. doi: 10.1186/s12889-022-14908-w. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.El-Zein M, Ramanakumar AV, Naud P, et al. Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young women. Sex Transm Dis. 2019 Oct;46(10):663–669. doi: 10.1097/OLQ.0000000000001053. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Guo C, Zhan B, Li MY, Yue L, Zhang C. Association between oral contraceptives and cervical cancer: a retrospective case-control study based on the National Health and Nutrition Examination Survey. Front Pharmacol. 2024;15:1400667. doi: 10.3389/fphar.2024.1400667. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Torres-Poveda K, Ruiz-Fraga I, Madrid-Marina V, Chavez M, Richardson V. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program. BMC Cancer. 2019 Dec 10;19(1):1205. doi: 10.1186/s12885-019-6388-4. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Feature scaling in machine learning: standardization, MinMaxScaling and more. Train In Data. [18-08-2025]. https://www.blog.trainindata.com/feature-scaling-in-machine-learning/#:~:text=Many%20machine%20learning%20algorithms%20are%20sensitive URL. Accessed.
  • 24.Vyas A, Raman S, Sen S, et al. Machine learning-based diagnosis and ranking of risk factors for diabetic retinopathy in population-based studies from South India. Diagnostics (Basel) 2023 Jun 16;13(12):2084. doi: 10.3390/diagnostics13122084. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Muraina I. Ideal dataset splitting ratios in machine learning algorithms: general concerns for data scientists and data analysts. 7th International Mardin Artuklu scientific research conference; Dec 10-12, 2021; Mardin, Turkey. [04-09-2025]. Presented at. URL. Accessed. [Google Scholar]
  • 26.10 techniques to handle imbalanced classes in machine learning. Analytics Vidhya. [18-08-2025]. https://www.analyticsvidhya.com/articles/class-imbalance-in-machine-learning URL. Accessed.
  • 27.The DHS Program. [18-08-2025]. https://dhsprogram.com/ URL. Accessed.
  • 28.Cervical cancer. World Health Organization African region. [18-08-2025]. https://www.afro.who.int/health-topics/cervical-cancer URL. Accessed.
  • 29.Shocking statistics: cervical cancer claims 70% of cases in Africa, experts call for action. Top Africa news. [18-08-2025]. https://www.topafricanews.com/2025/04/24 URL. Accessed.
  • 30.AfricaCDC; [04-09-2025]. Continental consultative meeting report: accelerating the plan to eliminate cervical cancer in Africa by 2030.https://africacdc.org/download/continental-consultative-meeting-report-accelerating-the-plan-to-eliminate-cervical-cancer-in-africa-by-2030/ URL. Accessed. [Google Scholar]
  • 31.Reichheld A, Mukherjee PK, Rahman SM, David KV, Pricilla RA. Prevalence of cervical cancer screening and awareness among women in an urban community in South India-a cross sectional study. Ann Glob Health. 2020 Mar 16;86(1):30. doi: 10.5334/aogh.2735. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Desta M, Getaneh T, Yeserah B, et al. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(11):e0259339. doi: 10.1371/journal.pone.0259339. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ba DM, Ssentongo P, Musa J, et al. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: a population-based study. Cancer Epidemiol. 2021 Jun;72:101930. doi: 10.1016/j.canep.2021.101930. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Asgedom YS, Kassie GA, Habte A, Ketema DB, Aragaw FM. Socioeconomic inequality in cervical cancer screening uptake among women in sub-Saharan Africa: a decomposition analysis of Demographic and Health Survey data. BMJ Open. 2024 Dec 10;14(12):e088753. doi: 10.1136/bmjopen-2024-088753. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Isabirye A, Mbonye MK, Kwagala B. Predictors of cervical cancer screening uptake in two districts of Central Uganda. PLoS ONE. 2020;15(12):e0243281. doi: 10.1371/journal.pone.0243281. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Miles-Richardson S, Allen S, Claridy MD, Booker EA, Gerbi G. Factors associated with self-reported cervical cancer screening among women aged 18 years and older in the United States. J Community Health. 2017 Feb;42(1):72–77. doi: 10.1007/s10900-016-0231-5. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 37.Misgun T, Demissie DB. Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia. BMC Cancer. 2023 Oct 10;23(1):961. doi: 10.1186/s12885-023-11478-x. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Amado G, Weldegebreal F, Birhanu S, Dessie Y. Cervical cancer screening practices and its associated factors among females of reproductive age in Durame town, Southern Ethiopia. PLoS ONE. 2022;17(12):e0279870. doi: 10.1371/journal.pone.0279870. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bendahhou K, Serhier Z, Diouny S, et al. Women’s knowledge and attitudes towards cervical cancer screening in Morocco. Cureus. 2023 Apr;15(4):e37989. doi: 10.7759/cureus.37989. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Macleod CI, Reynolds JH. Human papilloma virus infection and cervical cancer among women who sell sex in Eastern and Southern Africa: a scoping review. Womens Health (Lond) 2021;17:17455065211058349. doi: 10.1177/17455065211058349. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.McCarthy SH, Walmer KA, Boggan JC, et al. Awareness of cervical cancer causes and predeterminants of likelihood to screen among women in Haiti. J Low Genit Tract Dis. 2017 Jan;21(1):37–41. doi: 10.1097/LGT.0000000000000281. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Groves S, Brooks J. What do young women below national screening age in England think about cervical cancer and cervical screening? A qualitative study. J Clin Nurs. 2022 Jun;31(11-12):1588–1597. doi: 10.1111/jocn.16012. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 43.Irino S, Ose H, Takata N, Kamoshida S, Ohsaki H. Barriers to undergoing cervical cancer screening among health sciences university students in Japan: a cross-sectional study. Nurs Health Sci. 2023 Sep;25(3):466–473. doi: 10.1111/nhs.13043. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 44.Ghahramani F, Wang J. Impact of smartphones on quality of life: a health information behavior perspective. Inf Syst Front. 2020 Dec;22(6):1275–1290. doi: 10.1007/s10796-019-09931-z. doi. [DOI] [Google Scholar]
  • 45.Choi Y, Ibrahim S, Park LP, Cohen CR, Bukusi EA, Huchko MJ. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya. BMC Womens Health. 2022 Apr 18;22(1):122. doi: 10.1186/s12905-022-01702-4. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Emru K, Abebaw TA, Abera A. Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: a cross-sectional study. Womens Health (Lond) 2021;17:17455065211017041. doi: 10.1177/17455065211017041. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lin S, Chen WT, Gu C, Cheng HL, Wang H, Tang S. Knowledge, perception of HIV symptom severity and cervical cancer screening behaviour among women living with HIV in China. Eur J Cancer Care (Engl) 2022 Mar;31(2):e13542. doi: 10.1111/ecc.13542. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 48.Ninsiima M, Nyabigambo A, Kagaayi J. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda. BMC Health Serv Res. 2023 Apr 3;23(1):333. doi: 10.1186/s12913-023-09326-6. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brown RF, Muller TR, Olsen A. Australian women’s cervical cancer screening attendance as a function of screening barriers and facilitators. Soc Sci Med. 2019 Jan;220:396–402. doi: 10.1016/j.socscimed.2018.11.038. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 50.Eastment MC, Wanje G, Richardson BA, et al. A cross-sectional study of the prevalence, barriers, and facilitators of cervical cancer screening in family planning clinics in Mombasa County, Kenya. BMC Health Serv Res. 2022 Dec 23;22(1):1577. doi: 10.1186/s12913-022-08984-2. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ghosh S, Mallya SD, Shetty RS, et al. Knowledge, attitude and practices towards cervical cancer and its screening among women from tribal population: a community-based study from Southern India. J Racial Ethn Health Disparities. 2021 Feb;8(1):88–93. doi: 10.1007/s40615-020-00760-4. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rimande-Joel R, Ekenedo GO. Knowledge, belief and practice of cervical cancer screening and prevention among women of Taraba, North-East Nigeria. Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3291–3298. doi: 10.31557/APJCP.2019.20.11.3291. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Stuart A, Obiri-Yeboah D, Adu-Sarkodie Y, Hayfron-Benjamin A, Akorsu AD, Mayaud P. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening. BMC Womens Health. 2019 Oct 23;19(1):123. doi: 10.1186/s12905-019-0818-y. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Mekonnen AG, Mittiku YM. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: a review of literature. PLOS Glob Public Health. 2023;3(3):e0000941. doi: 10.1371/journal.pgph.0000941. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Olubodun T, Ogundele OO, Salisu ZA, Odusolu YO, Caleb-Ugwuowo UU. Cervical cancer awareness and risk factors among women residing in an urban slum in Lagos, Southwest Nigeria. Afr Health Sci. 2023 Sep;23(3):269–279. doi: 10.4314/ahs.v23i3.33. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Tesfaw K, Kindie W, Mulatu K, Bogale EK. Utilisation of cervical cancer screening and factors associated with screening utilisation among women aged 30-49 years in Mertule Mariam Town, East Gojjam Zone, Ethiopia, in 2021: a cross-sectional survey. BMJ Open. 2022 Nov 22;12(11):e067229. doi: 10.1136/bmjopen-2022-067229. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Isabirye A. Individual and intimate-partner factors associated with cervical cancer screening in Central Uganda. PLoS One. 2022;17(9):e0274602. doi: 10.1371/journal.pone.0274602. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kim S, Lee SY, Choi-Kwon S. Cervical cancer screening and human papillomavirus vaccination among Korean sexual minority women by sex of their sexual partners. Int J Environ Res Public Health. 2020 Nov 30;17(23):8924. doi: 10.3390/ijerph17238924. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Teame H, Gebremariam L, Kahsay T, Berhe K, Gebreheat G, Gebremariam G. Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia, 2018; case control study. PLoS One. 2019;14(3):e0213546. doi: 10.1371/journal.pone.0213546. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Urquhart G, Maclennan SJ, Guntupalli AM. Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan? PLoS One. 2023;18(8):e0290678. doi: 10.1371/journal.pone.0290678. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.CervixCheck information for healthcare providers. CancerCare Manitoba. [04-09-2025]. https://www.cancercare.mb.ca/screening/hcp/cervix URL. Accessed.
  • 62.Cartwright K, Kosich M, Gonya M, et al. Cervical cancer knowledge and screening patterns in Zuni Pueblo Women in the Southwest United States. J Cancer Educ. 2023 Oct;38(5):1531–1538. doi: 10.1007/s13187-023-02295-8. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Covaliu BF, Forray AI, Tomic M, et al. Understanding cervical cancer screening attendance: barriers and facilitators in a representative population survey. Cancers (Basel) 2025 Feb 19;17(4):706. doi: 10.3390/cancers17040706. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Fang CY, Ma GX, Handorf EA, et al. Addressing multilevel barriers to cervical cancer screening in Korean American women: a randomized trial of a community-based intervention. Cancer. 2017 May 15;123(6):1018–1026. doi: 10.1002/cncr.30391. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Nakisige C, Trawin J, Mitchell-Foster S, et al. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol. BMC Public Health. 2020 Jan 31;20(1):142. doi: 10.1186/s12889-020-8216-9. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Williams MS, Kenu E, Adanu A, et al. Awareness and beliefs about cervical cancer, the HPV vaccine, and cervical cancer screening among Ghanaian women with diverse education levels. J Cancer Educ. 2019 Oct;34(5):897–903. doi: 10.1007/s13187-018-1392-y. doi. Medline. [DOI] [PubMed] [Google Scholar]
  • 67.Rosyda R, Santoso B, Yunitasari E. Is an educational level affect women’s participation on cervical cancer screening? - a systematic review. The 9th International Nursing Conference; Apr 7-8, 2018; Surabaya East Java, Indonesia. Presented at. doi. [DOI] [Google Scholar]
  • 68.Adzigbli LA, Aboagye RG, Adeleye K, Osborne A, Ahinkorah BO. Cervical cancer screening uptake and its predictors among women aged 30-49 in Ghana: providing evidence to support the World Health Organization’s cervical cancer elimination initiative. BMC Infect Dis. 2025 Feb 21;25(1):246. doi: 10.1186/s12879-025-10485-6. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Paneru B, Karmacharya A, Bharati A, et al. Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal. PLoS ONE. 2023;18(5):e0285771. doi: 10.1371/journal.pone.0285771. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Zhang M, Zhong Y, Zhao Z, et al. Cervical cancer screening rates among Chinese women - China, 2015. China CDC Wkly. 2020 Jun 26;2(26):481–486. doi: 10.46234/ccdcw2020.128. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Zhetpisbayeva I, Kassymbekova F, Sarmuldayeva S, Semenova Y, Glushkova N. Cervical cancer prevention in rural areas. Ann Glob Health. 2023;89(1):75. doi: 10.5334/aogh.4133. doi. Medline. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Measuredhs. [19-08-2025]. https://www.measuredhs.com/ URL. Accessed.

Articles from JMIR Public Health and Surveillance are provided here courtesy of JMIR Publications Inc.

RESOURCES